DK159278B - Fremgangsmaade til fremstilling af depolymeriseret heparin - Google Patents

Fremgangsmaade til fremstilling af depolymeriseret heparin Download PDF

Info

Publication number
DK159278B
DK159278B DK349678A DK349678A DK159278B DK 159278 B DK159278 B DK 159278B DK 349678 A DK349678 A DK 349678A DK 349678 A DK349678 A DK 349678A DK 159278 B DK159278 B DK 159278B
Authority
DK
Denmark
Prior art keywords
heparin
product
solution
molecular weight
hydrolysis
Prior art date
Application number
DK349678A
Other languages
Danish (da)
English (en)
Other versions
DK349678A (da
Inventor
Fernando Fussi
Gianfranco Fedeli
Original Assignee
Hepar Chimie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11219874&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK159278(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hepar Chimie Sa filed Critical Hepar Chimie Sa
Publication of DK349678A publication Critical patent/DK349678A/da
Publication of DK159278B publication Critical patent/DK159278B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK349678A 1977-08-09 1978-08-08 Fremgangsmaade til fremstilling af depolymeriseret heparin DK159278B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT26608/77A IT1083903B (it) 1977-08-09 1977-08-09 Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
IT2660877 1977-08-09

Publications (2)

Publication Number Publication Date
DK349678A DK349678A (da) 1979-02-10
DK159278B true DK159278B (da) 1990-09-24

Family

ID=11219874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK349678A DK159278B (da) 1977-08-09 1978-08-08 Fremgangsmaade til fremstilling af depolymeriseret heparin

Country Status (10)

Country Link
US (1) US4757057A (es)
JP (1) JPS5430277A (es)
AU (1) AU3873878A (es)
CH (1) CH642979A5 (es)
DE (1) DE2833898A1 (es)
DK (1) DK159278B (es)
ES (1) ES472934A1 (es)
FR (1) FR2400037A1 (es)
GB (1) GB2002406B (es)
IT (1) IT1083903B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35770E (en) * 1978-11-06 1998-04-14 Choay, S.A. Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
FR2461719A2 (fr) * 1979-07-20 1981-02-06 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4826827A (en) * 1979-10-05 1989-05-02 Choay S.A. Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
JPS56120704A (en) * 1980-01-28 1981-09-22 Hepar Ind Inc Method of obtaining low molecular weight heparin having heightened pharmacologic property* product manufactured thereby and its use
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2538404B1 (es) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US4942156A (en) * 1986-08-20 1990-07-17 Hepar Industries, Inc. Low molecular weight heparin derivatives having improved anti-Xa specificity
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
US4745106A (en) * 1986-08-20 1988-05-17 Griffin Charles C Heparin derivatives having improved anti-Xa specificity
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
US7387253B1 (en) 1996-09-03 2008-06-17 Hand Held Products, Inc. Optical reader system comprising local host processor and optical reader
US5784102A (en) * 1995-05-15 1998-07-21 Welch Allyn, Inc. Optical reader having improved interactive image sensing and control circuitry
AU1173599A (en) * 1997-11-20 1999-06-15 Ikuo Yamashina Low-molecular heparin modification and remedy for skin ulcer
EP2249284B1 (en) 2001-01-22 2014-03-05 Hand Held Products, Inc. Optical reader having partial frame operating mode
US7270273B2 (en) 2001-01-22 2007-09-18 Hand Held Products, Inc. Optical reader having partial frame operating mode
US7268924B2 (en) 2001-01-22 2007-09-11 Hand Held Products, Inc. Optical reader having reduced parameter determination delay
EP1582531A1 (en) * 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
JP4679138B2 (ja) * 2004-12-24 2011-04-27 株式会社日本バリアフリー 高純度化されたムコ多糖類の製造方法
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes
EP4182452A4 (en) 2020-07-14 2024-07-31 Optimvia Llc METHOD FOR THE SYNTHESIS OF NON-ANTICOAGULATING HEPARAN SULFATE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB674607A (en) * 1949-10-20 1952-06-25 Roche Products Ltd Process for the manufacture of substances preventing the coagulation of blood
US2832766A (en) * 1952-04-17 1958-04-29 Univ Ohio State Res Found Sulfated aminopolysaccharides
DE968752C (de) * 1954-01-29 1958-03-27 Hoffmann La Roche Verfahren zur Herstellung von Chondroitinpolyschwefelsaeureestern
DE1032731B (de) * 1955-09-22 1958-06-26 Upjohn Co Verfahren zur selektiven Sulfatierung von Aminoalkoholen in der Aminogruppe
US3585184A (en) * 1967-12-29 1971-06-15 Univ Ohio State 2-amino - 2 - deoxy-d-glucopyrano-d-glucopyranans having the alpha-d-glucose configuration,method,and use

Also Published As

Publication number Publication date
GB2002406A (en) 1979-02-21
DE2833898A1 (de) 1979-02-22
JPS5430277A (en) 1979-03-06
GB2002406B (en) 1982-10-20
AU3873878A (en) 1980-02-14
ES472934A1 (es) 1979-10-16
DE2833898C2 (es) 1988-06-23
FR2400037A1 (fr) 1979-03-09
CH642979A5 (it) 1984-05-15
DK349678A (da) 1979-02-10
IT1083903B (it) 1985-05-25
FR2400037B1 (es) 1980-06-20
JPS6234041B2 (es) 1987-07-24
US4757057A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
DK159278B (da) Fremgangsmaade til fremstilling af depolymeriseret heparin
US4281108A (en) Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
FI104490B (fi) Menetelmä terapeuttisesti käyttökelpoisten sulfatoitujen polysakkaridiseosten valmistamiseksi
Mätzsch et al. Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers
US5280016A (en) Non-anticoagulant heparin derivatives
US5250519A (en) Non-anticoagulant heparin derivatives
US5696100A (en) Method for controlling O-desulfation of heparin and compositions produced thereby
US4533549A (en) Antithrombotic agent
US5922690A (en) Dermatan disulfate, an inhibitor of thrombin generation and activation
US3766167A (en) Orally active anticoagulant
Thomas et al. A low molecular weight heparin compared with unfractionated heparin
NZ206697A (en) Depolymerised and supersulphated heparin and pharmaceutical compositions
JP5351770B2 (ja) ビオチンまたはビオチン誘導体との少なくとも１つの共有結合を含む低分子量ヘパリン、これらの作製方法およびそれらの使用。
US6150342A (en) Heparin derivatives for treatment of angina pectoris
US4438108A (en) Anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
US4783447A (en) Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use
DE3422518A1 (de) Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US5403827A (en) Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them
JPH0442401B2 (es)
US20100075922A1 (en) Heparins including at least one covalent bond with biotin or a biotin derivative, method for preparing same and use thereof
US20020009782A1 (en) Heparin and heparan sulfate derived oligosaccharides and a method for their manufacture
JP4633223B2 (ja) 血管内皮細胞増殖因子依存性血管内皮細胞増殖の抑制剤
JP2005505537A (ja) 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物
RU2176915C2 (ru) Полусинтетические сульфаминогепаросансульфаты, имеющие высокую антиметастатическую активность и пониженный геморрагический риск
EP0209924A1 (en) New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions